✦ LIBER ✦

SAFETY AND EFFICACY OF SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (mRCC): PRELIMINARY ASSESSMENT OF AN ITALIAN EXPANDED-ACCESS PROGRAM (EAP) WITH SUBPOPULATION ANALYSIS

✍ Scribed by Sternberg, Cora N; Porta, Camillo; Bracarda, Sergio; Carteni, Giacomo; Re, Giovanni Lo; Ruggeri, Enzo M; Conte, Pierfranco; Monfardini, Silvio; Gasparini, Giampietro; Ciuffreda, Libero; Marini, Giovanni; Bonetti, Andrea; Heouaine, Abdhelhamid; Bernardini, Ilaria; Ravaioli, Alberto; Labianca, Roberto

Book ID: 123251509
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 191 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61225-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4503 ORAL Sunitinib in metastatic renal

4503 ORAL Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis

✍ Gore, M.; Szczylik, C.; Porta, C.; Bracarda, S.; Hawkins, R.; Bjarnason, G.; Oud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

SAFETY AND EFFICACY OF SUNITINIB IN AN E

SAFETY AND EFFICACY OF SUNITINIB IN AN EXPANDED-ACCESS TRIAL OF METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND SUBPOPULATION ANALYSIS

✍ S. Oudard; C. Szczylik; C. Porta; S. Bracarda; R. Hawkins; G. Bjarnason; S.H. Le 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Safety and efficacy of sunitinib for met

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

✍ Martin E Gore; Cezary Szczylik; Camillo Porta; Sergio Bracarda; Georg A Bjarnaso 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 143 KB

7118 An Asian subpopulation analysis of

7118 An Asian subpopulation analysis of the safety and efficacy of sunitinib in metastatic renal cell carcinoma

✍ Lee, S.; Chung, H.C.; Mainwaring, P.; Ng, C.; Chang, J.W.C.; Kwong, P.; Li, R.K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

248 SUNITINIB IN PATIENTS (PTS) WITH OR

248 SUNITINIB IN PATIENTS (PTS) WITH OR WITHOUT PRIOR NEPHRECTOMY IN AN EXPANDED-ACCESS STUDY OF METASTATIC RENAL CELL CARCINOMA (MRCC)

✍ C. Szczylik; C. Porta; S. Bracarda; R. Hawkins; G.A. Bjarnason; S. Oudard; S.H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 546 KB

7154 An International Expanded Access Pr

7154 An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy

✍ Grünwald, V.; Rah, S.Y.; Miller, K.; Karakiewicz, P.I.; Machiels, J.P.; Hajdenbe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB